---
title: "000504.SZ (000504.SZ) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/000504.SZ/news.md"
symbol: "000504.SZ"
name: "000504.SZ"
parent: "https://longbridge.com/zh-HK/quote/000504.SZ.md"
datetime: "2026-03-14T04:48:59.406Z"
locales:
  - [en](https://longbridge.com/en/quote/000504.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/000504.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/000504.SZ/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/000504.SZ/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/000504.SZ/news.md)


# 000504.SZ (000504.SZ) — 相關新聞

### [Landfar: The company warns of the risk of its stock being delisted](https://longbridge.com/zh-HK/news/277342883.md)
*2026-03-01T07:39:41.000Z*
> Landfar announced that for the fiscal year 2024, the company's total profit, net profit, and net profit after deducting 

### [Landfar: 2024 revenue fails to meet standards, stock may be delisted](https://longbridge.com/zh-HK/news/274959528.md)
*2026-02-05T11:05:59.000Z*
> ST Landfar announced that for the fiscal year 2024, the company's total profit, net profit, and net profit after deducti

### [Breaking! 000504, major asset restructuring terminated!](https://longbridge.com/zh-HK/news/273381409.md)
*2026-01-22T13:36:52.000Z*
> Landfar (000504) major asset restructuring has concluded. Landfar announced on January 22 that the company disclosed the

### [ST Landfar terminates the acquisition of 51% equity in Hunan Huize Bio](https://longbridge.com/zh-HK/news/273375580.md)
*2026-01-22T12:59:10.000Z*
> ST Landfar announced the termination of the plan to acquire 51% equity of Hunan Huize Biotechnology. Despite multiple co

### [ST Landfar expects to turn a profit, with a projected net profit attributable to shareholders of RMB 28.5 million to RMB 32.5 million in 2025](https://longbridge.com/zh-HK/news/273375425.md)
*2026-01-22T12:57:12.000Z*
> ST Landfar expects a net profit attributable to shareholders of RMB 28.5 million to RMB 32.5 million in 2025, successful

### [Nanhua Biological: Revenue of 385-425 million in 2025, achieving a turnaround to profitability](https://longbridge.com/zh-HK/news/273369595.md)
*2026-01-22T12:08:12.000Z*
> Nanhua Biological expects to achieve revenue of 385-425 million yuan and a net profit of 28.5-32.5 million yuan in 2025,

### [Government subsidies + cross-border new energy + planning major asset restructuring, can *ST Landfar cross the delisting "death line"?](https://longbridge.com/zh-HK/news/269182700.md)
*2025-12-10T05:33:08.000Z*
> Landfar recently received a government subsidy of 4.8 million yuan but still faces the risk of delisting. In 2024, the o

### [Nanhua Bio plans to acquire a controlling stake in Jinhong New Materials for 78.62 million, restructuring dual main businesses to combat delisting risks](https://longbridge.com/zh-HK/news/256946260.md)
*2025-09-09T03:30:10.000Z*
> Nanhua Biomedical Co., Ltd. (*ST Landfar) plans to acquire a 43.05% stake in Loudi Jinhong New Materials Co., Ltd. for 7

### [After acquiring a CRO company, *ST Landfar is continuously investing in new energy](https://longbridge.com/zh-HK/news/256396143.md)
*2025-09-08T12:30:07.000Z*
> ST Landfar (000504), facing the risk of delisting, continues to pursue acquisitions, planning to acquire a controlling s